Table 3 Client follow-up, partner uptake, use and entry into care

Total distributed

5,368 (52.3%)

4,422 (43.1%)

466 (4.5%)

3,296 (79.3%)

790 (19.0%)

68 (1.6%)

Client follow-up

 Consented to follow-up

5,270 (98.2%)

4,276 (96.7%)

408 (87.6%)

3,257 (98.8%)

757 (95.8%)

52 (76.5%)

 Successful interview 1

1,478 (28.0%)

940 (22.0%)

64 (15.7%)

666 (20.4%)

117 (15.5%)

9 (17.3%)

 Successful interview 2

479 (9.1%)

373 (8.7%)

3 (0.7%)

246 (7.6%)

56 (7.4%)

0 (0.0%)

 Successful interview 3

490 (9.3%)

381 (8.9%)

5 (1.2%)

486 (14.9%)

68 (9.0%)

1 (1.9%)

 Days to 1^st interview

16 (16.0)

17 (13.0)

30 (75.0)

17 (17.0)

15 (77.0)

30 (224.0)

 Days to 2^nd interview

33 (42.0)

39 (37.0)

7 (5.0)

29.0 (28.0)

41 (19.5)

10.0 (6.0)

 Days to 3^rd interview

9 (33.0)

21.5 (60.0)

11 (4.0)

33 (51.0)

22 (54.0)

11 (2.0)

 Total successfully followed up

2,461 (46.4%)

1,702 (39.6%)

72 (17.6%)

1,398 (42.9%)

241 (31.8%)

10 (19.2%)

Partner uptake & use

 Offered partner kit

2,098 (85.2%)

1,320 (77.6%)

57 (79.2%)

1,114 (79.9%)

192 (79.7%)

6 (60.0%)

 Partner took kit

2,047 (97.6%)

1,311 (99.3%)

51 (89.5%)

1,065 (95.6%)

186 (96.9%)

6 (100.0%)

 Partner used kit

1,995 (97.5%)

1,285 (98.0%)

48 (94.1%)

1,019 (95.7%)

181 (97.3%)

6 (100.0%)

Entry into Care

 HIVST Reactive result

105 (5.3%)

52 (4.1%)

2 (4.2%)

247 (24.2%)

48 (26.5%)

2 (33.3%)

 Attended confirmatory testing

85 (81.0%)

40 (76.9%)

2 (100.0%)

218 (88.3%)

41 (85.4%)

2 (100.0%)

 Confirmed HIV + 

80 (94.1%)

34 (85.0)

2 (100.0%)

218 (100.0%)

40 (97.6%)

2 (100.0%)

 Initiated on ART

79 (98.8%)

34 (100.0%)

1 (50.0%)

216 (99.1%)

40 (100.0%)

2 (100.0%)

 Time to ART initiation Median (IQR)

0 (0.0)

0 (0.0)

15 (0.0)

0 (0.0)

0 (0.0)

10.5 (7.0)